After securing more than $60 million in funding from Immatics Biotechnologies GmbH (Immatics) and the Cancer Prevention and Research Institute of Texas (CPRIT), The University of Texas MD Anderson Cancer Center announced it will join with Immatics in a brand-new venture: the formation of ImmaticOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.